Global Newswire by Notified: M&A

JULY 31, 2024

Otsuka Pharmaceutical to acquire Jnana Therapeutics Inc.

Pharmaceutical 89

Pharmaceutical 89

PE Hub

JANUARY 17, 2024

The post PE-backed Alcami acquires Pacific Pharmaceutical Services appeared first on PE Hub. Alcami is a contract development and manufacturing organization.

Pharmaceutical 76

Pharmaceutical Manufacturing 76

CNBC: Investing

AUGUST 10, 2024

The Japanese pharmaceutical company is grappling with a scandal, and Oasis thinks it can help right the ship.

Pharmaceutical 93

Pharmaceutical IT 93

Global Newswire by Notified: M&A

MARCH 20, 2024

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

Pharmaceutical 89

Pharmaceutical Mergers IT 89

Global Newswire by Notified: M&A

SEPTEMBER 16, 2024

16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” PRINCETON, N.J., ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. Nasdaq: ALIM) (“Alimera”).

Pharmaceutical 49

Pharmaceutical Acquisitions IT 49

PE Hub

JANUARY 3, 2024

The post Avista-backed Cosette Pharmaceuticals acquires women’s sexual health brand Vyleesi appeared first on PE Hub. The seller was Palatin Technologies Inc.

Pharmaceutical 84

Pharmaceutical 84

Global Newswire by Notified: M&A

AUGUST 15, 2024

Protect Pharmaceutical Corp. PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger.

Pharmaceutical 85

Pharmaceutical Mergers 85

Global Newswire by Notified: M&A

SEPTEMBER 16, 2024

16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. PRINCETON, N.J., Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced acquisition of Alimera Sciences, Inc. Nasdaq: ALIM).

Pharmaceutical 45

Pharmaceutical Acquisitions 45

Global Banking & Finance

AUGUST 7, 2024

July 2024 – The pharmaceutical industry is making remarkable progress in its quest for decarbonisation, with emissions already on a significant decline. Yet, the journey to Net Zero remains fraught with challenges, particularly in curbing Scope 3 emissions within the workplace.

Pharmaceutical 52

Pharmaceutical IT Business 52

Global Newswire by Notified: M&A

JULY 28, 2023

Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3

Pharmaceutical 76

Pharmaceutical Shares 76

Global Newswire by Notified: M&A

SEPTEMBER 26, 2024

Pharmaceutical Excipients Market size was valued at USD 10.12 Pharmaceutical Excipients Market size was valued at USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031). billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8%

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

OCTOBER 21, 2024

21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn ™ (iloprost IV), the only FDA approved treatment option for severe frostbite in the US, from CiVi Biopharma. Philadelphia, PA, Oct. Aurlumyn™ will be made available this coming winter season.

Pharmaceutical 40

Pharmaceutical Acquisitions Portfolio 40

PE Hub

SEPTEMBER 22, 2023

The post Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals appeared first on PE Hub. The purchase price is about $462 million.

Pharmaceutical 79

Pharmaceutical 79

Global Newswire by Notified: M&A

OCTOBER 17, 2024

PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder, as previously announced PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder, as previously (..)

Pharmaceutical 40

Pharmaceutical Manufacturing IT 40

Global Newswire by Notified: M&A

SEPTEMBER 10, 2024

10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” PRINCETON, N.J., ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. Alimera”) (Nasdaq: ALIM).

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

OCTOBER 17, 2024

AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

Pharmaceutical 45

Pharmaceutical Healthcare Acquisitions IT 45

Global Newswire by Notified: M&A

JUNE 9, 2024

Selechimica”), an Italian distributor in the pharmaceutical industry. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L.

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

PE Hub

JUNE 6, 2023

The post Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m appeared first on PE Hub. Oaktree Capital Management will provide $175 million in debt financing for this deal.

Pharmaceutical 74

Pharmaceutical Debt Finance Finance 74

Global Newswire by Notified: M&A

JULY 24, 2024

Westford,USA, July 24, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Pharmaceutical Packaging Market will attain a value of USD 301.23 These include designing, distributing and manufacturing packaging materials to help meet the unique needs of the pharmaceutical packaging industry. billion by 2031, with a CAGR of 9.9%

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

Global Newswire by Notified: M&A

MARCH 21, 2024

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

APRIL 23, 2024

a European distributor in the pharmaceutical and nutraceutical industry. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Spain has signed an agreement to acquire 100% of the shares in Cobapharma, S.L.U,

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

AUGUST 19, 2024

19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. NEW YORK, Aug. NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the “Merger Agreement”) regarding a business combination with KE Sdn. The Merger Agreement was approved by Titan’s board of directors (the “Board”).

Pharmaceutical 53

Pharmaceutical Mergers Shares Business 53

Global Newswire by Notified: M&A

JULY 1, 2024

Protect Pharmaceutical Corp. Issues Corporate Update.

Pharmaceutical 49

Pharmaceutical Corporation 49

PE Hub

NOVEMBER 14, 2023

The post Nordic Capital bets it can help the pharmaceutical industry speed up technology adoption appeared first on PE Hub. Nordic is acquiring the majority stake in IntegriChain, a Philadelphia-based provider of technology for the life sciences industry, from Accel-KKR.

Pharmaceutical 65

Pharmaceutical Capital IT 65

Global Newswire by Notified: M&A

DECEMBER 4, 2023

Rising demand for functional excipients and oral pharmaceutical medicines and increasing number of pharmaceuticals industries across the globe are key factors driving Pharmaceutical Excipients market revenue growth.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

OCTOBER 4, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals.

Pharmaceutical 49

Pharmaceutical Mergers 49

Global Newswire by Notified: M&A

AUGUST 3, 2023

SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 billion by 2030, with a CAGR of 6.9% over the forecast period (2023-2030).

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Global Newswire by Notified: M&A

JANUARY 4, 2024

Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (API) market revenue growth Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (..)

Pharmaceutical 40

Pharmaceutical 40

JD Supra: Mergers

SEPTEMBER 27, 2024

On September 11-12, we had the pleasure of attending the LSX World Congress USA in Boston, where leaders discussed the challenges and opportunities of M&A and partnerships in the pharmaceutical sector. By: A&O Shearman

Pharmaceutical 161

Pharmaceutical M&A 161

Global Newswire by Notified: M&A

JUNE 12, 2024

Westford USA, June 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Active Pharmaceutical Ingredients Market will attain a value of USD 351.81 Furthermore, the changing consumer taste towards personalized and precision medicine is expected to drive the active pharmaceutical ingredient (API) market. Billion by 2031, with a CAGR of 5.9%

Pharmaceutical 40

Pharmaceutical 40

JD Supra: Mergers

NOVEMBER 7, 2024

Alexion Pharmaceuticals, Inc., In Shareholder Representative Services LLC v. the Delaware Court of Chancery addressed an earnout dispute, holding that a buyer violated its contract with the seller by failing to use “commercially reasonable efforts” to meet the contractual milestones that would entitle the seller to a hefty earnout payment.

Pharmaceutical 161

Pharmaceutical IT 161

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

JANUARY 2, 2024

The global Pharmaceutical Packaging market size is expected to reach USD 249.41 Additionally, the rise in generic drug manufacturing, advancements in pharmaceutical technologies, and the push for sustainable and eco-friendly packaging options are also contributing factors fueling the market's growth.

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

JD Supra: Mergers

OCTOBER 30, 2024

Alexion Pharmaceuticals, Inc. Johnson & Johnson, the court awarded nearly $1 billion in damages for breach of contract to the target company’s stockholders, while the court in Shareholder Representative Services LLC v. will announce its damages determination. By: Mayer Brown

Pharmaceutical 167

Pharmaceutical IT 167

Global Banking & Finance

MARCH 5, 2024

Active Pharmaceutical Ingredients Market to hit $ 372.6 billion by 2030: Verified Market Reports The Global Active Pharmaceutical Ingredients Market size was valued at USD 237.3 Billion in 2023 and is expected to reach USD 372.6 Billion by the end of 2030 with a CAGR of 6.9% During the Forecast Period 2023-2030.

Pharmaceutical 40

Pharmaceutical 40